| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
REPORT
1Division of Endocrinology, Department of Medicine, University of Arkansas for Medical Sciences; and 2The Central Arkansas Veterans HealthCare System, Little Rock, Arkansas 72205
Submitted 25 April 2003 ; accepted in final form 6 February 2004
ABSTRACT
Obesity-related insulin resistance may be caused by adipokines such as IL-6, which is known to be elevated with the insulin resistance syndrome. A previous study reported that IL-6 knockout mice (IL-6–/–) developed maturity onset obesity, with disturbed carbohydrate and lipid metabolism, and increased leptin levels. Because IL-6 is associated with insulin resistance, one might have expected IL-6–/– mice to be more insulin sensitive. We examined body weights of growing and older IL-6–/– mice and found them to be similar to wild-type (IL-6+/+) mice. Dual-energy X-ray absorptiometry analysis at 3 and 14 mo revealed no differences in body composition. There were no differences in fasting blood insulin and glucose or in triglycerides. To further characterize these mice, we fed 11-mo-old IL-6–/– and IL-6+/+ mice a high- (HF)- or low-fat diet for 14 wk, followed by insulin (ITT) and glucose tolerance tests (GTT). An ITT showed insulin resistance in the HF animals but no difference due to genotype. In the GTT, IL-6–/– mice demonstrated elevated postinjection glucose levels by 60% compared with IL-6+/+ but only in the HF group. Although IL-6–/– mice gained weight and white adipose tissue (WAT) with the HF diet, they gained less weight than the IL-6+/+ mice. Total lipoprotein lipase activity in WAT, muscle, and postheparin plasma was unchanged in the IL-6 –/– mice compared with IL-6+/+ mice. There were no differences in plasma leptin or TNF-
due to genotype. Plasma adiponectin was 
53% higher (71.7 ± 14.1 µg/ml) in IL-6–/– mice than in IL-6+/+ mice but only in the HF group. Thus these data show that IL-6–/– mice do not demonstrate obesity, fasting hyperglycemia, or abnormal lipid metabolism, although HF IL-6–/– mice demonstrate elevated glucose after a GTT.
interleukin-6; adipose tissue
This article has been cited by other articles:
|
|
 |
|
  B. K. Pedersen Edward F. Adolph Distinguished Lecture: Muscle as an endocrine organ: IL-6 and other myokines J Appl Physiol, October 1, 2009; 107(4): 1006 - 1014. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. S. C. Gollisch, J. Brandauer, N. Jessen, T. Toyoda, A. Nayer, M. F. Hirshman, and L. J. Goodyear Effects of exercise training on subcutaneous and visceral adipose tissue in normal- and high-fat diet-fed rats Am J Physiol Endocrinol Metab, August 1, 2009; 297(2): E495 - E504. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D.-E. Lee, S. Kehlenbrink, H. Lee, M. Hawkins, and J. S. Yudkin Getting the message across: mechanisms of physiological cross talk by adipose tissue Am J Physiol Endocrinol Metab, June 1, 2009; 296(6): E1210 - E1229. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. K. Pedersen and M. A. Febbraio Muscle as an Endocrine Organ: Focus on Muscle-Derived Interleukin-6 Physiol Rev, October 1, 2008; 88(4): 1379 - 1406. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Ellingsgaard, J. A. Ehses, E. B. Hammar, L. Van Lommel, R. Quintens, G. Martens, J. Kerr-Conte, F. Pattou, T. Berney, D. Pipeleers, et al. Interleukin-6 regulates pancreatic {alpha}-cell mass expansion PNAS, September 2, 2008; 105(35): 13163 - 13168. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. G. Gosman, H. I. Katcher, and R. S. Legro Obesity and the role of gut and adipose hormones in female reproduction Hum. Reprod. Update, September 1, 2006; 12(5): 585 - 601. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Bamoulid, C. Courivaud, M. Deschamps, P. Mercier, C. Ferrand, A. Penfornis, P. Tiberghien, J.-M. Chalopin, P. Saas, and D. Ducloux IL-6 Promoter Polymorphism -174 Is Associated with New-Onset Diabetes after Transplantation J. Am. Soc. Nephrol., August 1, 2006; 17(8): 2333 - 2340. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Krogh-Madsen, P. Plomgaard, K. Moller, B. Mittendorfer, and B. K. Pedersen Influence of TNF-{alpha} and IL-6 infusions on insulin sensitivity and expression of IL-18 in humans Am J Physiol Endocrinol Metab, July 1, 2006; 291(1): E108 - E114. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. C. Garcia, I. Wernstedt, A. Berndtsson, M. Enge, M. Bell, O. Hultgren, M. Horn, B. Ahren, S. Enerback, C. Ohlsson, et al. Mature-onset obesity in interleukin-1 receptor I knockout mice. Diabetes, May 1, 2006; 55(5): 1205 - 1213. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Spranger, S. Verma, I. Gohring, T. Bobbert, J. Seifert, A. L. Sindler, A. Pfeiffer, S. M. Hileman, M. Tschop, and W. A. Banks Adiponectin Does Not Cross the Blood-Brain Barrier but Modifies Cytokine Expression of Brain Endothelial Cells Diabetes, January 1, 2006; 55(1): 141 - 147. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. P. Kristiansen and T. Mandrup-Poulsen Interleukin-6 and Diabetes: The Good, the Bad, or the Indifferent? Diabetes, December 1, 2005; 54(suppl_2): S114 - S124. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-H. Yu and H. N. Ginsberg Adipocyte Signaling and Lipid Homeostasis: Sequelae of Insulin-Resistant Adipose Tissue Circ. Res., May 27, 2005; 96(10): 1042 - 1052. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
